These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Initial management of children with newly diagnosed idiopathic thrombocytopenic purpura in the Nordic countries. Treutiger I; Rajantie J; Zeller B; Elinder G; Rosthöj S; NOPHO ITP Working Group Acta Paediatr; 2006 Jun; 95(6):726-31. PubMed ID: 16754555 [TBL] [Abstract][Full Text] [Related]
3. Predictors of chronic idiopathic thrombocytopenic purpura. ElAlfy M; Farid S; Abdel Maksoud A Pediatr Blood Cancer; 2010 Jul; 54(7):959-62. PubMed ID: 20405514 [TBL] [Abstract][Full Text] [Related]
4. Duration and morbidity of chronic immune thrombocytopenic purpura in children: five-year follow-up of a Nordic cohort. Rosthøj S; Rajantie J; Treutiger I; Zeller B; Tedgård U; Henter JI; Acta Paediatr; 2012 Jul; 101(7):761-6. PubMed ID: 22429281 [TBL] [Abstract][Full Text] [Related]
5. A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura. Fujisawa K; Iyori H; Ohkawa H; Konishi S; Bessho F; Shirahata A; Miyazaki S; Akatsuka J; Int J Hematol; 2000 Oct; 72(3):376-83. PubMed ID: 11185998 [TBL] [Abstract][Full Text] [Related]
6. Intended management of children with acute idiopathic thrombocytopenic purpura: a national survey. Marks MK; Vadamalayan B; Ekert H; South MJ J Paediatr Child Health; 2005; 41(1-2):52-5. PubMed ID: 15670225 [TBL] [Abstract][Full Text] [Related]
7. [Epidemiology, disease presentation and course of idiopathic thrombocytopenic purpura in Danish children from 1998-2000]. Kjaersgaard M; Edslev PW; Rosthøj S Ugeskr Laeger; 2008 May; 170(22):1922-6. PubMed ID: 18513475 [TBL] [Abstract][Full Text] [Related]
8. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309 [TBL] [Abstract][Full Text] [Related]
9. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS). Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971 [TBL] [Abstract][Full Text] [Related]
10. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura. Erduran E; Aslan Y; Gedik Y; Orhan F Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792 [TBL] [Abstract][Full Text] [Related]
11. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center. Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808 [TBL] [Abstract][Full Text] [Related]
12. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607 [TBL] [Abstract][Full Text] [Related]
13. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy. Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000 [TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289 [TBL] [Abstract][Full Text] [Related]
15. Experience with high dose dexamethasone in the treatment of chronic symptomatic immune thrombocytopaenia. Van Riet FA; Wessels G; Hesseling PB East Afr Med J; 1999 Oct; 76(10):571-4. PubMed ID: 10734508 [TBL] [Abstract][Full Text] [Related]
17. Treatment of idiopathic thrombocytopenic purpura (ITP) in patients with refractoriness to or with contraindication for corticosteroids and/or splenectomy with immunosuppressive therapy and danazol. Schiavotto C; Castaman G; Rodeghiero F Haematologica; 1993; 78(6 Suppl 2):29-34. PubMed ID: 8039755 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of immune thrombocytopenic purpura in Pediatrics. Therapeutic efficacy of a regional intravenous immunoglobulin G]. Buteler C; Colombo H; Gabosi G; Manfredi MJ; Montero S; Pasquali MA; Rougier C; Sisti AM Medicina (B Aires); 2001; 61(5 Pt 1):522-8. PubMed ID: 11721317 [TBL] [Abstract][Full Text] [Related]
19. [Childhood idiopathic thrombocytopenic purpura (the results of 20-year experience)]. Kvezereli-Kopadze MA; Kvezereli-Kopadze AN; Mtvarelidze ZG Georgian Med News; 2009 Sep; (174):50-5. PubMed ID: 19801732 [TBL] [Abstract][Full Text] [Related]
20. Idiopathic thrombocytopenic purpura: a 15-year natural history study at the Children's Hospital Rijeka, Croatia. Roganovic J; Letica-Crepulja M Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):662-4. PubMed ID: 16933251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]